HOME
OUR FOCUS
OUR TEAM
NEWS
More
Bexson Biomedical Announces Two New Appointments to Board of Directors
Ketamine: The Psychedelic Painkiller that Could Halt the Opioid Crisis? Double Blind Magazine
Bexson Biomedical’s Chief Scientific Officer speaks to ketamine leaders at ASKP conference
Bexson Biomedical files second provisional patent family
Bexson Biomedical receives Orphan designation
Bexson Biomedical Adds Industry Leaders Bill Carson And Noah Craft As Advisors
July 2020 -- Investor Presentation
